Tenax Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-8.8M | $-43.9M | $-14.1M | $-19.5M | $-9.4M | $-15.7M | $10.4M |
| Depreciation & Amortization | $13.6K | $19.0K | $148.1K | $150.5K | $148.8K | $206.7K | $311.0K |
| Depreciation | $13.6K | $19.0K | $77.8K | $88.3K | $93.0K | — | — |
| Amortization | — | $0 | $70.3K | $62.2K | $55.8K | $45.2K | — |
| Stock-Based Compensation | $79.6K | $1.1K | $117.3K | $651.5K | $185.3K | $127.5K | $59.4K |
| Net Cash from Operating Activities | $-12.1M | $-15.9M | $-9.7M | $-9.3M | $-4.9M | $-8.3M | $-8.4M |
| Investing Activities | |||||||
| Capital Expenditures | $4.5K | $2.9K | $4.2K | $9.8K | $17.2K | $17.7K | $240.8K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $3.7M | $22.2M | $-40.9M | $-147.0K | $-148.0K | $-261.1K | $-463.9K |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $0 | $280.6K | $66.9M | $4.0M | $9.5M | $9.2M |
| Net Change in Cash | $-8.4M | $6.3M | $-50.4M | $57.5M | $-1.1M | $927.9K | $319.2K |
| Free Cash Flow | $-12.1M | $-15.9M | $-9.8M | $-9.3M | $-4.9M | $-8.3M | $-8.6M |